Tiam1 Protein Expression in Primary and Metastatic Colorectal Carcinoma: A Retrospective Study of 200 Cases
Objective: T-cell Lymphoma Invasion and Metastasis 1 (Tiam1)protein is a guanine nucleotide exchange factor that activates proteins of the Rho family of GTPases, specifically Rac1. Expression of Tiam1 protein has been reported in various human cancers and has been associated with lymphangiogenesis and promotion of tumor metastasis. The objective of this study was to further evaluate the expression of Tiam1 in primary and metastatic colorectal cancer (CRC) and its association withvariousclinicopathological parameters, includinggender, age, tumor size, Dukes stage, tumor grade, lymph node status and original location of the primary tumor (colon versus rectum).
Methods: The expression of Tiam1 was detected by immunohistochemistry in 200 samples of primary CRC tissues and in 100 samples of lymph node tissue with CRC metastases.
Results: Tiam1 was overexpressed in the majority of both primary (69,5% of the cases) and metastatic (63% of the cases) CRC tumor tissues. Overexpression of Tiam1 in primary CRC was statistically associated withlowertumor grade(P=0,04), whereas in metastatic CRC a statistically significant association between Tiam1 expression and female gender (P=0,003), tumor size >5cm (P=0,001) and localization of the primary tumor in the colon (P=0,009) was found.
Conclusion: Overexpression of Tiam1 protein may represent a frequent event in CRC. Additional studies are warranted to further investigate its potential value as a marker of prognosis and treatment response in this form of cancer.
FerlayJ, ShinHR, BrayF, FormanD, MathersC, ParkinDM. Estimatesofworldwideburdenofcancer in2008: GLOBOCAN2008.Int J Cancer. 2010, 127: 2893-917
EdwardsMS, ChaddaSD, ZhaoZ, BarberBL, SykesDP. Asystematicreviewoftreatment guidelinesformetastaticcolorectalcancer. Colorectal Dis. 2012, 14: e31-47
MoorcraftSY, SmythEC, CunninghamD. Theroleof personalizedmedicineinmetastaticcolorectalcancer: anevolvinglandscape. TherapAdvGastroenterol. 2013, 6: 381-95
Michiels F, Habets GG, Stam JC, van der Kammen RA, Collard JC. A role for Rac in Tiam1-induced membrane ruffling and invasion. Nature. 1995, 375:338-340
SaxenaM, DykesSS, MalyarchukS, WangAE, CardelliJA, PruittK. Thesirtuinspromotedisheveled-1scaffoldingofTIAM1, Racactivationandcellmigration. Oncogene. 2013,doi: 10.1038/onc.2013.549
BoissierP, Huynh-Do U. TheguaninenucleotidechangefactorTiam1: aJanus-facedmoleculeincellularsignaling. Cell Signal. 2014, 26:483-91
Chardin P, Boquet P, Madaule P, Popoff MR, Rubin EJ, Gill DM. The mammalian G protein RhoC is ADP-ribosylated by Clostridium botulinum exoenzyme C3 and affects actin microfilaments in Vero cells. EMBO J. 1989, 8:1087-1092
Olson MF, Ashworth A, Hall A. An essential role for Rho, Rac and Cdc42 GTPases in cell cycle progression through G1. Nature. 1995, 269:1270-1272
Habets GG, Scholtes EH, Zuydgeest D, van der Kammen RA, Stam JC, Berns A, Collard JG. Identification of an invasion-inducing gene, Tiam1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins. Cell. 1994, 77:537-549
vanLeeuwen FN, van der Kammen RA, Habets GG, Collard JG. Oncogenic activity of Tiam1 and Rac1 in NIH3T3 cells. Oncogene. 1995, 11:2215-2221
Malliri A, van der Kammen RA, Clark K, van der Valk M, Michiels F, Collard JC. Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumors. Nature. 2002, 417:867-871
Zhao L, Liu Y, Sun X, He M, Ding Y. Overexpression of T lymphoma invasion and metastasis 1 predict renal cell carcinoma metastasis and overall patient survival. J Cancer Res ClinOncol. 2011, 137:393-398.
Adam L, Vadlamudi RK, McCrea P, Kumar R. Tiam1 overexpression potentiates heregulin-induced lymphoid enhancer factor-1/beta-catenin nuclear signaling in breast cancer cells by modulating the intercellular stability. J Biol Chem. 2001, 276:28443-28450
Engers R, Mueller M, Walter A, Collard JG, Willers R, Gabbert HE. Prognostic relevance of Tiam1 protein expression in prostate carcinomas. British J Cancer. 2006,95:1081-1086.
Ding Y, Chen B, Wang S, Zhao L, Chen J, Ding Y, Chen L, Luo R. Overexpression of Tiam1 in hepatocellular carcinomas predicts poor prognosis of HCC patients. Int J Cancer. 2009, 124:653-658
WHO classification of tumors. Pathology and genetics. Tumors of the digestive system. Lyon IARC Press, 2000, pp103-119
AJCC Cancer Staging Atlas. Springer Verlag, New York Inc, 2003, 6thed.
Dukes CE. The classification of cancer of the rectum. Journal of pathology and Bacteriology. 1932, 35:323-332
WalchA, SeidlS, HermannstadterC, RauserS, DeplazesJ, LangerR.etal. CombinedanalysisofRac1, IQGAP1, Tiam1andE-cadherinexpressioningastriccancer. Mod Pathol. 2008, 21: 544-52
Liu l, Zhang Q, Zhang Y, Wang S, Ding Y. Lentivirus-mediated silencing of Tiam1 gene influences multiple functions of a human colorectal cancer cell line. Neoplasia. 2006, 8:917-924
Malliri A, Rygiel TP, van der Kammen RA, Song JY, Engers R, Hurlstone AF, Clevers H, Collard JG. The Rac activator Tiam1 is a Wnt-responsive gene that modifies intestinal tumor development. J Biol Chem. 2006, 281:543-548
Oving IM, Clevers HC. Molecular causes of colon cancer. Eur J Clin Invest. 2002, 32:448-457
Minard M.E., Herynk M.H., Collard J.G., Gallick G.E. The guanine nucleotide exchange factor Tiam1 increases colon carcinoma growth at metastatic sites in an orthotopic nude mouse model. Oncogene. 2005, 24:2568-2573
Zhong D, Li Y, Peng Q, Zhou J, Zhou Q, Zhang R, Liang H. Expression of Tiam1 and VEGF-C correlates with lymphangiogenesis in human colorectal carcinoma. Cancer Biology and Therapy. 2009, 8:689-695
- There are currently no refbacks.